S. Harari, E. Lau, and Y. Tamura, Rare (pulmonary) disease day: ???feeding the breath, energy for life!???, European Respiratory Journal, vol.45, issue.2, pp.297-300, 2015.
DOI : 10.1183/09031936.00221914

N. Kamel, European reference networks: moving towards a tangible outcome of the European Union's cross-border healthcare directive?, European Respiratory Journal, vol.48, issue.6, pp.1564-1568, 2016.
DOI : 10.1183/13993003.01385-2016

F. Bonella, M. Wijsenbeek, and M. Molina-molina, European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers, European Respiratory Journal, vol.47, issue.2, pp.597-606, 2016.
DOI : 10.1183/13993003.01204-2015

A. Fischer, K. Antoniou, and K. Brown, An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features, European Respiratory Journal, vol.46, issue.4, pp.976-987, 2015.
DOI : 10.1183/13993003.00150-2015

J. Behr, M. Kreuter, and M. Hoeper, Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry, European Respiratory Journal, vol.46, issue.1, pp.186-196, 2015.
DOI : 10.1183/09031936.00217614

C. Ryerson, V. Cottin, and K. Brown, Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm, European Respiratory Journal, vol.46, issue.2, pp.512-520, 2015.
DOI : 10.1183/13993003.00419-2015

H. Collard, W. Bradford, and V. Cottin, A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials, European Respiratory Journal, vol.46, issue.1, pp.243-249, 2015.
DOI : 10.1183/09031936.00200614

S. Harari, O. Torre, R. Cassandro, and J. Moss, The changing face of a rare disease: lymphangioleiomyomatosis, European Respiratory Journal, vol.46, issue.5, pp.1471-1485, 2015.
DOI : 10.1183/13993003.00412-2015

A. Taveira-dasilva, A. Jones, and P. Julien-williams, Severity and outcome of cystic lung disease in women with tuberous sclerosis complex, European Respiratory Journal, vol.45, issue.1, pp.171-180, 2015.
DOI : 10.1183/09031936.00088314

S. Mourah, A. How-kit, and V. Meignin, mutations in pulmonary Langerhans cell histiocytosis, European Respiratory Journal, vol.47, issue.6, pp.1785-1796, 2016.
DOI : 10.1183/13993003.01677-2015

R. Borie, L. Tabèze, and G. Thabut, mutations in suspected genetic pulmonary fibrosis, European Respiratory Journal, vol.48, issue.6, pp.1721-1731, 2016.
DOI : 10.1183/13993003.02115-2015
URL : https://hal.archives-ouvertes.fr/hal-01467555

C. Newton, K. Batra, and J. Torrealba, Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive, European Respiratory Journal, vol.48, issue.6, pp.1710-1720, 2016.
DOI : 10.1183/13993003.00308-2016

A. Clement, J. De-blic, and R. Epaud, Management of children with interstitial lung diseases: the difficult issue of acute exacerbations: TABLE 1, European Respiratory Journal, vol.48, issue.6, pp.1559-1563, 2016.
DOI : 10.1183/13993003.01900-2016

H. De-keyser, B. Brussels, G. Patient, . Meszaros, H. Budapest et al., ILD core network coordinator F. Bonella, Essen, Germany CF core network coordinator K. van der Ent The Netherlands PCD core network coordinator H nCF-BE core network coordinator J, Chalmers, Dundee, UK AATD core network coordinator J. Stolk, Leiden, The Netherlands MSTO core network coordinator J. Aerts, Rotterdam, The Netherlands CLAD core network coordinator G, Committee position Candidate Patient representative PH core network vice coordinator N. Galiè

H. Nunes, K. Schubel, and D. Piver, Nonspecific interstitial pneumonia: survival is influenced by the underlying cause, European Respiratory Journal, vol.45, issue.3, pp.746-755, 2015.
DOI : 10.1183/09031936.00148613

Y. Cozier, Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions, European Respiratory Journal, vol.48, issue.6, pp.1545-1548, 2016.
DOI : 10.1183/13993003.01819-2016

Y. Jamilloux, D. Maucort-boulch, and S. Kerever, Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis, European Respiratory Journal, vol.48, issue.6, pp.1700-1709, 2016.
DOI : 10.1183/13993003.00457-2016

E. Arkema, J. Grunewald, and S. Kullberg, Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden, European Respiratory Journal, vol.48, issue.6, pp.1690-1699, 2016.
DOI : 10.1183/13993003.00477-2016

L. Li, L. Silveira, and N. Hamzeh, Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis, European Respiratory Journal, vol.47, issue.6, pp.1797-1808, 2016.
DOI : 10.1183/13993003.01469-2015
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134922

J. Elborn, S. Bell, and S. Madge, Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis, European Respiratory Journal, vol.47, issue.2, pp.420-428, 2016.
DOI : 10.1183/13993003.00592-2015

P. Burgel, G. Bellis, and H. Olesen, Future trends in cystic fibrosis demography in 34 European countries, European Respiratory Journal, vol.46, issue.1, pp.133-141, 2015.
DOI : 10.1183/09031936.00196314

A. Stephenson, M. Tom, and Y. Berthiaume, A contemporary survival analysis of individuals with cystic fibrosis: a cohort study, European Respiratory Journal, vol.45, issue.3, pp.670-679, 2015.
DOI : 10.1183/09031936.00119714

F. Braido, I. Baiardini, and M. Sumberesi, Public awareness on cystic fibrosis: results from a national pragmatic survey, European Respiratory Journal, vol.46, issue.1, pp.264-267, 2015.
DOI : 10.1183/09031936.00221014

N. Galiè, M. Humbert, and J. Vachiery, 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, European Respiratory Journal, vol.46, issue.4, pp.903-975, 2015.
DOI : 10.1183/13993003.01032-2015

D. Montani, E. Lau, and P. Dorfmüller, Pulmonary veno-occlusive disease, European Respiratory Journal, vol.47, issue.5, pp.1518-1534, 2016.
DOI : 10.1183/13993003.00026-2016
URL : https://hal.archives-ouvertes.fr/inserm-01436297

B. Girerd, D. Montani, and X. Jaïs, Genetic counselling in a national referral centre for pulmonary hypertension, European Respiratory Journal, vol.47, issue.2, pp.541-552, 2016.
DOI : 10.1183/13993003.00717-2015

L. Savale, M. Chaumais, and O. Sitbon, Pulmonary arterial hypertension in patients treated with interferon: TABLE 1, European Respiratory Journal, vol.46, issue.6, pp.1851-1853, 2015.
DOI : 10.1183/13993003.01376-2015

M. Eyries, M. Szezepanski, and I. , Genetic analyses in a cohort of children with pulmonary hypertension, Eur Respir J, vol.48, pp.1118-1126, 2016.

M. Ghigna, C. Guignabert, and D. Montani, mutation status influences bronchial vascular changes in pulmonary arterial hypertension, European Respiratory Journal, vol.48, issue.6, pp.1668-1681, 2016.
DOI : 10.1183/13993003.00464-2016

J. Lucas, A. Barbato, and S. Collins, European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia, European Respiratory Journal, vol.49, issue.1, p.1601090, 2017.
DOI : 10.1183/13993003.01090-2016

L. , D. Galvin, A. Rubbo, and B. , Diagnosing primary ciliary dyskinesia: an international patient perspective, Eur Respir J, vol.48, pp.1096-1107, 2016.

M. Goutaki, A. Meier, and F. Halbeisen, Clinical manifestations in primary ciliary dyskinesia: systematic review and meta-analysis, European Respiratory Journal, vol.48, issue.4, pp.1081-1095, 2016.
DOI : 10.1183/13993003.00736-2016

C. Werner, M. Lablans, and M. Ataian, An international registry for primary ciliary dyskinesia, European Respiratory Journal, vol.47, issue.3, pp.849-859, 2016.
DOI : 10.1183/13993003.00776-2015

C. Jackson, L. Behan, and S. Collins, Accuracy of diagnostic testing in primary ciliary dyskinesia, European Respiratory Journal, vol.47, issue.3, pp.837-848, 2016.
DOI : 10.1183/13993003.00749-2015

J. Lucas, L. Behan, D. Galvin, and A. , A quality-of-life measure for adults with primary ciliary dyskinesia: QOL???PCD, European Respiratory Journal, vol.46, issue.2, pp.375-383, 2015.
DOI : 10.1183/09031936.00216214

J. Chalmers, S. Aliberti, and F. Blasi, Management of bronchiectasis in adults, European Respiratory Journal, vol.45, issue.5, pp.1446-1462, 2015.
DOI : 10.1183/09031936.00119114

S. Aliberti, S. Masefield, and E. Polverino, Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration, European Respiratory Journal, vol.48, issue.3, pp.632-647, 2016.
DOI : 10.1183/13993003.01888-2015

S. Aliberti, S. Lonni, and S. Dore, Clinical phenotypes in adult patients with bronchiectasis, European Respiratory Journal, vol.47, issue.4, pp.1113-1122, 2016.
DOI : 10.1183/13993003.01899-2015

T. Greulich, C. Nell, and D. Hohmann, -antitrypsin deficiency and its comorbidities: results from a large population-based database, European Respiratory Journal, vol.49, issue.1, p.1600154, 2017.
DOI : 10.1183/13993003.00154-2016
URL : https://hal.archives-ouvertes.fr/halshs-00078534

J. Ji, J. Sundquist, and K. Sundquist, Incidence and familial risk of pleural mesothelioma in Sweden: a national cohort study, European Respiratory Journal, vol.48, issue.3, pp.873-879, 2016.
DOI : 10.1183/13993003.00091-2016

K. Meyer, G. Raghu, and G. Verleden, An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome, European Respiratory Journal, vol.44, issue.6, pp.1479-1503, 2014.
DOI : 10.1183/09031936.00107514

D. Ruttens, S. Verleden, and E. Bijnens, An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe, European Respiratory Journal, vol.49, issue.1, p.1600484, 2017.
DOI : 10.1183/13993003.00484-2016

M. Benmerad, R. Slama, and K. Botturi, Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study, European Respiratory Journal, vol.49, issue.1, p.1600206, 2017.
DOI : 10.1183/13993003.00206-2016

W. Randerath, J. Verbraecken, and S. Andreas, Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep, European Respiratory Journal, vol.49, issue.1, p.1600959, 2017.
DOI : 10.1183/13993003.00959-2016

V. Cottin, E. Bel, and P. Bottero, Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg???Strauss), European Respiratory Journal, vol.48, issue.5, pp.1429-1441, 2016.
DOI : 10.1183/13993003.00097-2016
URL : https://hal.archives-ouvertes.fr/hal-01406073

V. Vorselaars, S. Velthuis, and R. Snijder, Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia, European Respiratory Journal, vol.47, issue.6, pp.1750-1757, 2016.
DOI : 10.1183/13993003.01588-2015

S. Kotecha, A. Barbato, and A. Bush, Congenital diaphragmatic hernia, European Respiratory Journal, vol.39, issue.4, pp.820-829, 2012.
DOI : 10.1183/09031936.00066511

S. Harari, M. Humbert, and F. Blasi, Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?, European Respiratory Review, vol.24, issue.137, pp.375-377, 2015.
DOI : 10.1183/16000617.0051-2015
URL : http://doi.org/10.1183/16000617.0051-2015

S. Harari and H. M. , Toward better management of rare and orphan pulmonary diseases, European Respiratory Journal, vol.47, issue.5, pp.1334-1335, 2016.
DOI : 10.1183/13993003.00390-2016